SCYNEXIS
SCYX
#10667
Rank
HK$0.18 B
Marketcap
HK$18.66
Share price
-8.64%
Change (1 day)
306.26%
Change (1 year)

EPS for SCYNEXIS (SCYX)

EPS in 2026 (TTM): -HK$40.69

According to SCYNEXIS's latest financial reports the company's current EPS (TTM) is -HK$40.76. In 2025 the company made an earnings per share (EPS) of -HK$10.66 an increase over its 2024 EPS that were of -HK$27.59.

EPS history for SCYNEXIS from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-HK$40.69281.7%
2025-HK$10.66-61.36%
2024-HK$27.59-131.43%
2023HK$87.80-195.24%
2022-HK$92.1917.6%
2021-HK$78.39-75.73%
2020-HK$322.96-46.24%
2019-HK$600.77242.14%
2018-HK$175.59-70.21%
2017-HK$589.49-40.51%
2016-HK$990.84-41.04%
2015-HK$1,681157.69%
2014-HK$652.20-96.49%
2013-HK$18,565307.85%
2012-HK$4,552

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Galmed Pharmaceuticals
GLMD
-HK$100.97 147.69%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Catalyst Pharmaceuticals
CPRX
HK$14.19-134.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalent
CTLT
-HK$49.62 21.73%๐Ÿ‡บ๐Ÿ‡ธ USA
KemPharm
KMPH
-HK$7.76-80.96%๐Ÿ‡บ๐Ÿ‡ธ USA